Deka Biosciences Closes USD $20 Million Series B2 Financing Led by MPM BioImpact
GERMANTOWN, Md., [September 28, 2023] – Maryland-based biotech company Deka Biosciences ("Deka") today announced that it has successfully closed a USD $20 Million Series B2 financing with a syndicate of…